Selective COX-2 inhibitor reduces bone healing in bone defects
Open Access
- 1 December 2005
- journal article
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 19 (4) , 312-316
Abstract
Anti-inflammatory agents have been reported to regulate bone healing. The aim of this study was to investigate the effect of a selective cyclooxygenase-2 inhibitor (meloxicam) on bone healing in calvarial defects in rats. Thirty-six adult male Wistar rats were included. After anesthesia, a linear incision was made through the skin of the scalp, a full-thickness flap was reflected and a 4 mm round defect was made with a trephine drill. The animals were randomly assigned to one of the following 4 treatment groups (9 animals each), including daily subcutaneous injections: A: saline solution for 15 days; B: saline solution for 45 days; C: 3 mg/kg of meloxicam for 15 days and D: 3 mg/kg of meloxicam for 45 days. The animals were sacrificed and the specimens, routinely processed. The bone filling was histometrically measured and statistical analysis, performed. Intergroup comparisons demonstrated that the meloxicam groups presented a significant reduction in bone healing when compared to their respective controls (group A, 44.5 ± 5.75%, against group C, 57.5 ± 7.25%, p < 0.05; group B, 40.25 ± 13.75%, against group D, 52.25 ± 17.25%). Within the limits of the present study, it can be concluded that selective cyclooxygenase-2 inhibitors may reduce bone healing in calvarial defects in rats after continuous administration.Keywords
This publication has 18 references indexed in Scilit:
- COX inhibitors and their effects on bone healingExpert Opinion on Drug Safety, 2004
- Effect of COX-2-Specific Inhibition on Fracture-Healing in the Rat FemurJournal of Bone and Joint Surgery, 2004
- Differential inhibition of fracture healing by non‐selective and cyclooxygenase‐2 selective non‐steroidal anti‐inflammatory drugsJournal of Orthopaedic Research, 2003
- Effect of tenoxicam on fracture healing in rat tibiaeInjury, 2003
- COX‐2 selective NSAID decreases bone ingrowth in vivoJournal of Orthopaedic Research, 2002
- THE EFFECT OF CYCLOOXYGENASE-2 INHIBITORS ON SPINAL FUSIONJournal of Bone and Joint Surgery, 2002
- The Effect of Postsurgical Naproxen and a Bioabsorbable Membrane on Osseous Healing in Intrabony DefectsJournal of Periodontology, 1999
- Importance of the Critical-Size Bone Defect in Testing Bone-Regenerating MaterialsJournal of Craniofacial Surgery, 1998
- Effect of Nonsteroidal Antiinflammatory Drugs on Fracture HealingJournal of Orthopaedic Trauma, 1995
- The Critical Size Defect as an Experimental Model To Test Bone Repair MaterialsJournal of Craniofacial Surgery, 1990